Preferential inhibition of paraoxonase activity of human paraoxonase 1 by negatively charged lipids

To determine the causes responsible for a preferential decrease of paraoxonase activity, which has been observed in the serum of patients with cardiovascular diseases, the inactivation or inhibition of paraoxonase 1 (PON1) by various endogenous factors was examined using paraoxon or phenyl acetate a...

Full description

Bibliographic Details
Main Authors: Su Duy Nguyen, Dai-Eun Sok
Format: Article
Language:English
Published: Elsevier 2004-12-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520341006
id doaj-aa5b5639b9ce4059a708d70a4f2693ee
record_format Article
spelling doaj-aa5b5639b9ce4059a708d70a4f2693ee2021-04-27T04:46:43ZengElsevierJournal of Lipid Research0022-22752004-12-01451222112220Preferential inhibition of paraoxonase activity of human paraoxonase 1 by negatively charged lipidsSu Duy Nguyen0Dai-Eun Sok1College of Pharmacy, Chungnam National University, Yuseong-Ku, Taejon 305-764, KoreaCollege of Pharmacy, Chungnam National University, Yuseong-Ku, Taejon 305-764, KoreaTo determine the causes responsible for a preferential decrease of paraoxonase activity, which has been observed in the serum of patients with cardiovascular diseases, the inactivation or inhibition of paraoxonase 1 (PON1) by various endogenous factors was examined using paraoxon or phenyl acetate as a substrate. When purified PON1 was incubated with various endogenous oxidants or aldehydes, they failed to cause a preferential reduction of paraoxonase activity, suggesting no participation of the inactivation mechanism in the preferential loss of paraoxonase activity. Next, when we examined the inhibition of PON1 activity by endogenous lipids, monoenoic acids such as palmitoleic acid or oleic acid inhibited paraoxonase activity preferentially, in contrast to a parallel inhibition of both activities by polyunsaturated or saturated acids. Noteworthy, oleoylglycine inhibited paraoxonase activity, but not arylesterase activity, complying with the selective inhibition of paraoxonase activity. Moreover, such a selective inhibition of paraoxonase activity was also expressed by lysophosphatidylglycerol or lysophosphatidylinositol, but not by lysophosphatidylserine or lysophosphatidylcholine, indicating the importance of the type of head group. Furthermore, such a preferential or selective inhibition of paraoxonase activity was also observed with PON1 associated with HDL or plasma.These data suggest that some negatively charged lipids may correspond to factors causing the preferential inhibition of paraoxonase activity of PON1.http://www.sciencedirect.com/science/article/pii/S0022227520341006paraoxonase 1oxidative inactivationphospholipidlysophospholipids
collection DOAJ
language English
format Article
sources DOAJ
author Su Duy Nguyen
Dai-Eun Sok
spellingShingle Su Duy Nguyen
Dai-Eun Sok
Preferential inhibition of paraoxonase activity of human paraoxonase 1 by negatively charged lipids
Journal of Lipid Research
paraoxonase 1
oxidative inactivation
phospholipid
lysophospholipids
author_facet Su Duy Nguyen
Dai-Eun Sok
author_sort Su Duy Nguyen
title Preferential inhibition of paraoxonase activity of human paraoxonase 1 by negatively charged lipids
title_short Preferential inhibition of paraoxonase activity of human paraoxonase 1 by negatively charged lipids
title_full Preferential inhibition of paraoxonase activity of human paraoxonase 1 by negatively charged lipids
title_fullStr Preferential inhibition of paraoxonase activity of human paraoxonase 1 by negatively charged lipids
title_full_unstemmed Preferential inhibition of paraoxonase activity of human paraoxonase 1 by negatively charged lipids
title_sort preferential inhibition of paraoxonase activity of human paraoxonase 1 by negatively charged lipids
publisher Elsevier
series Journal of Lipid Research
issn 0022-2275
publishDate 2004-12-01
description To determine the causes responsible for a preferential decrease of paraoxonase activity, which has been observed in the serum of patients with cardiovascular diseases, the inactivation or inhibition of paraoxonase 1 (PON1) by various endogenous factors was examined using paraoxon or phenyl acetate as a substrate. When purified PON1 was incubated with various endogenous oxidants or aldehydes, they failed to cause a preferential reduction of paraoxonase activity, suggesting no participation of the inactivation mechanism in the preferential loss of paraoxonase activity. Next, when we examined the inhibition of PON1 activity by endogenous lipids, monoenoic acids such as palmitoleic acid or oleic acid inhibited paraoxonase activity preferentially, in contrast to a parallel inhibition of both activities by polyunsaturated or saturated acids. Noteworthy, oleoylglycine inhibited paraoxonase activity, but not arylesterase activity, complying with the selective inhibition of paraoxonase activity. Moreover, such a selective inhibition of paraoxonase activity was also expressed by lysophosphatidylglycerol or lysophosphatidylinositol, but not by lysophosphatidylserine or lysophosphatidylcholine, indicating the importance of the type of head group. Furthermore, such a preferential or selective inhibition of paraoxonase activity was also observed with PON1 associated with HDL or plasma.These data suggest that some negatively charged lipids may correspond to factors causing the preferential inhibition of paraoxonase activity of PON1.
topic paraoxonase 1
oxidative inactivation
phospholipid
lysophospholipids
url http://www.sciencedirect.com/science/article/pii/S0022227520341006
work_keys_str_mv AT suduynguyen preferentialinhibitionofparaoxonaseactivityofhumanparaoxonase1bynegativelychargedlipids
AT daieunsok preferentialinhibitionofparaoxonaseactivityofhumanparaoxonase1bynegativelychargedlipids
_version_ 1721506376159592448